2020-2027 Analysis and Review Amoxicillin Sodium Market

Amoxicillin Sodium Market

Amoxicillin Sodium Market By Clinical Application (Respiratory Infections, Urinary tract Infections and Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027

10-06-2020 REP-HC-5112 40 Tables 110 pages Format

The amoxicillin sodium market was valued at USD 653.1 Mn by 2019. The rising prevalence of lower respiratory tract infections worldwide is primarily driving the amoxicillin sodium market growth. Furthermore, the growing incidence of complicated urinary tract infections in the female population further accentuates the market growth.

Amoxicillin Sodium Market

Amoxicillin sodium is considered as a broad-spectrum antibiotic having potent bactericidal activity. It exerts its pharmacological activity by binding to and inactivating the penicillin-binding proteins which are located in the inner membrane of the bacterial cell wall. It is either used alone or in combination with potassium clavulanate to treat the streptococcal resistant infections. Amoxicillin sodium has a long duration of action and is recommended twice a day since 17% of the drug is bound to the protein in the serum, hence the drug needs to be taken under medical supervision to prevent the occurrence of any drug-related side effects.

The major segments related to the amoxicillin sodium market are: 

By Clinical Application (2017–2027; US$ Mn)

Respiratory Infections

Urinary Tract Infections

Others

By Distribution Channel (2017–2027; US$ Mn)

Hospital Pharmacy

Retail Pharmacy

Others

Geography Segment (2017–2027; US$ Mn)

North America

U.S.
Canada

Europe

United Kingdom
Germany
Russia
France
Italy
Spain
Ukraine
Rest of Europe

Asia Pacific

China
Japan
Rest of Asia Pacific

Latin America (LATAM)

Brazil
Mexico
Rest of Latin America

Middle East and Africa (MEA)

GCC
Rest of MEA 

Justification for study?

  • The intention of the study is to give a comprehensive outlook of the global amoxicillin sodium market
  • The overall segmentation of the amoxicillin sodium market, by clinical application, distribution channel, and geography is minutely studied. Respiratory infections and hospital pharmacy are dominating the clinical application and distribution channel segments respectively
  • Rising prevalence of respiratory infections worldwide
  • A constant rise in the number of patients suffering from urinary tract infections throughout the globe

Report gist?

  • The study of the global amoxicillin sodium market includes qualitative analysis of factors such as drivers, restraints, and opportunities
  • The report covers a qualitative and quantitative analysis of the overall market segmented on the basis of clinical application and distribution channel and categorization of the same at the geography level
  • This research report presents the analysis of each segment from 2017 to 2027 in which 2019 is considered as the base year. The compounded annual growth rate is calculated for the respective segments from 2020 to 2027

The study includes the profiles of major market players with a significant global and regional presence along with top company positioning. 

Significant customers?

  • This study is suitable for industry participants and stakeholders in the pharmaceutical manufacturers actively engaged in the production and marketing of amoxicillin sodium due to the  rising prevalence of respiratory infections worldwide
  • The report will benefit doctors prescribing amoxicillin sodium to patients suffering from urinary tract infections
  • Managers with financial institutions looking to publish recent and forecasted statistics pertaining to amoxicillin sodium market
  • Financial institutions, venture capitalist, analysts, investors, government organizations, policymakers, regulatory authorities, researchers, looking for insights into the market to determine future strategies 

Segment Analysis

Respiratory infections are representing the largest market share in the clinical application segment for the amoxicillin sodium market. As per the latest information provided by the World Bank data in 2017, approximately 2.56 million people died due to pneumonia worldwide. It is considered as first-line drug therapy for the treatment of tonsillopharnyx caused by a streptococcal bacterial infection. Amoxicillin sodium is used in combination with potassium clavulanate for the treatment of otitis media infection across all age groups. Urinary tract infection is going to showcase exemplary market growth during the forecast period owing to the rising prevalence of urinary tract infection caused due to E.coli infection. According to the recent research citings provided by the World Health Organization (WHO), approximately 150 million people worldwide are suffering from urinary tract infection.

Hospital pharmacy is currently leading the distribution channel segment for the amoxicillin sodium market. Severe drug-related adverse events such as wheezing, hives, yellowing of skins, etc. makes it necessary for precise drug compounding for amoxicillin sodium as per the physician's prescription to negate the outcome of any fatal health issues. Retail pharmacy is expected to register steady market growth in the near future on account of the availability of government-subsidized medicines at a low price and serves the medicinal requirements of people residing in remote locations.

North America is presently spearheading the geography segment for the amoxicillin sodium market. The rising prevalence of respiratory infections primarily drives market growth in the region. As per the latest research citings presented by the Center for Disease Control and Prevention (CDC), approximately 1 million U.S. citizens seek treatment for pneumonia each year. Additionally, the affordable reimbursement scenario for the amoxicillin sodium drug formulations further accentuates the market growth in the region. Europe is the second-largest regional segment for the amoxicillin sodium market. The nurturing regulatory environment provided by the European Medical Agency (EMA) for the manufacturing and distribution of amoxicillin sodium products determines the market growth in the region. The Asia Pacific is anticipated to be the fastest-growing regional segment for the amoxicillin sodium market. Flourishing generic drugs market and the emergence of local players together propel the market growth in the region.

Select License Type

$4,600
$6,600
$13,200

Safe and Secure SSL Encrypted

Have a Question?

We will help you find what you are looking for.

Call 1-518-730-1560

Contact sales

How can we help you?

Get in touch with us or find an office closest to you.